Researchers at the Institute of Biomedical Research of Bellvitge (IDIBELL), led by Dr. Eva Gonzalez-Suarez, have shown that pharmacological and genetic inhibition of signaling pathway RANK / RANKL leads to a significant reduction in recurrences and metastases in breast cancer in a mouse animal model. Their findings, published in Cancer Research, suggest that RANK inhibitors currently used in patients with osteoporosis and bone metastases may have potential for treating breast cancer.
Cancer stem cells (CSC) express high levels of RANK protein. "In fact, mortality in breast cancer is mainly due to survivor CSC after treatments, which are responsible for tumor recurrence and metastasis" explains Dr. González-Suárez. "Previous studies of this and other research groups have shown that inhibition of RANK pathway may prevent breast cancer, but no one had proven the potential of RANK pathway inhibitors in the treatment of disease." In their latest work, researchers show that inhibition of the RANK / RANKL signaling pathway could potentially be used as a new therapy in breast cancer; as Dr. González-Suárez puts it, "this inhibition does not reduce tumor growth, but promotes differentiation, reducing the population of CSC and impairing metastasis, which improves the prognosis."
Under normal conditions, the RANK / RANKL bone metabolism protein pair act as a translator of the information provided by sex hormones such as progesterone and sends a signal which stimulates the development of the mammary gland. This occurs in all women during pregnancy and during the menstrual cycle; however, if the signaling pathway is disregulated, mammary cells begin to divide and multiply and die when they should not, leading to breast cancer.
The finding published in Cancer Research is considered a breakthrough because inhibitors of the RANK signaling pathway are already approved for clinical use. In fact, such inhibitors are currently used to treat osteoporosis and in the prevention of skeletal-related events in patients suffering from bone metastases due to tumors. "As these preclinical experiments suggest, and given that the RANKL / RANK pathway plays an important role in the development of primary breast cancer, inhibitors could serve as a potential target for the prevention and nonsurgical treatment of breast cancer," the researcher concludes.
Materials provided by IDIBELL-Bellvitge Biomedical Research Institute. Note: Content may be edited for style and length.
Disclaimer: DoveMed is not responsible for the adapted accuracy of news releases posted to DoveMed by contributing universities and institutions.
Primary Resource:
Yoldi, G., Pellegrini, P., Trinidad, E. M., Cordero, A., Gomez-Miragaya, J., Serra-Musach, J., ... & González-Suárez, E. (2016). RANK signaling blockade reduces breast cancer recurrence by inducing tumor cell differentiation. Cancer Research.
and connect with fellow professionals
At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.
0 Comments
Please log in to post a comment.